Tirzepatide treatment in a first responder lifestyle setting
    Weight Loss

    Compounded · Rx required

    Tirzepatide

    The most effective weight loss medication available
    4.9(127 reviews)

    Tirzepatide

    Where are you in treatment?

    $179$116/ month$188 first order discount applied

    $349 total · 3 Months · Automatic Refills • Cancel Anytime

    Choose where you are in treatment to see your price.

    Tirzepatide care designed around everyday life

    The shifts, the calls, the sleep you never caught up on — it adds up. Let's fix it.

    How it works

    First responder in a fire station gym holding a phone showing the RespondWell intake steps

    Start

    Start from your phone

    Answer a few questions about your health and goals.

    Video visit with a licensed clinician on a phone screen

    Review

    A clinician reviews your requested treatment

    They decide whether treatment is appropriate. No video visit required in 41 states.

    RespondWell compounded tirzepatide weight loss vial with syringes and alcohol prep pads

    Delivered

    Your treatment ships

    One of our trusted pharmacy partners discreetly ships your medication to your doorstep.

    Tirzepatide treatment detail

    What Tirzepatide can do

    20.9% average weight loss in clinical trials.

    Tirzepatide is a groundbreaking dual GLP-1/GIP agonist that delivers superior weight loss results. Clinical studies demonstrate average weight loss of up to 20.9% of body weight over 72 weeks.

    Clinical outcomes based on published tirzepatide trials, including SURMOUNT-1 (weight loss)¹, SURPASS-2 (glucose & metabolic health)², SURPASS-4 (cardiovascular outcomes)³, and SURMOUNT-OSA (sleep apnea)⁴. Compounded versions of Tirzepatide are not associated with Eli Lilly & Company and/or its genuine MOUNJARO® and/or ZEPBOUND® products. Compounded versions of Tirzepatide are not FDA approved, and neither the FDA nor any global regulatory agency has reviewed these products for safety, quality, or efficacy. GLP-1s may cause serious side effects, including possible thyroid tumors, including cancer. See the 'Important Safety Information' links below for more details.

    01Oversight

    Physician reviewed

    02Dose

    Tirzepatide is administered as a once-weekly subcutaneous injection.

    03Frequency

    Weekly injection

    04Included

    Medication, supplies, provider messaging

    Frequently asked questions

    Everything else worth knowing about Tirzepatide.

    Tirzepatide is typically suitable for adults seeking substantial weight loss, especially if your BMI is over 27 with weight-related conditions or over 30. It's not recommended for people with a history of medullary thyroid cancer, pancreatitis or severe gastrointestinal disease.

    Clinical trials show weight-loss of up to 20.9% over 72 weeks. Most users notice reduced appetite and cravings within the first few weeks, with steady weight loss thereafter. It's important to note that compounded medications should not be presumed equivalent to their branded counterparts, and they are not reviewed by the FDA for safety or effectiveness.

    Tirzepatide is a dual agonist that targets both GLP-1 and GIP receptors, while semaglutide only targets GLP-1. This dual action often yields greater weight-loss results.

    The most common side effects are GI-related – nausea, constipation, diarrhea, vomiting, and stomach discomfort – and they often improve over time. We start low and increase doses gradually to help minimize side effects. Rare but serious risks have been reported, including pancreatitis, gallbladder problems, and kidney injury. Tell your care team before surgery/anesthesia, since GLP-1s can slow gastric emptying. Animal studies indicated a risk of thyroid C-cell tumors. The correlation to humans has not been established, but you should avoid GLP-1 medications if you or your family has a history of MTC or MEN2. Review Important Safety Information for full details.

    Most patients find them virtually painless. Our medications are administered subcutaneously (under the skin) — not intramuscularly — using the small insulin syringes our pharmacies send you. At 29–32 gauge, these needles are way finer and shorter than the 22–24 gauge needles you're accustomed to for things like flu shots. (Higher gauge = thinner needle.)

    Safety information

    Boxed warning: thyroid C-cell tumors

    • · Tirzepatide caused thyroid C-cell tumors in rodents. It is unknown whether it causes medullary thyroid carcinoma (MTC) in humans.
    • · Do not use if you or a family member has had MTC, or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
    • · Tell your provider immediately about a neck lump or swelling, hoarseness, trouble swallowing, or shortness of breath.

    Related treatments

    From $109/mo · 3 Months
    Semaglutide

    Semaglutide

    Proven GLP-1 medication for effective weight management

    Explore treatment
    RespondWell

    Healthcare that doesn't suck. Built by first responders, for first responders.

    Verify Approval for www.respondwell.healthColorado Company

    Connect

    ContactText us: (888) 893-8110

    Sign up to receive tips and offers:

    By submitting your email address you agree to receive emails from us. Privacy Policy.

    Ask AI about RespondWell

    © 2026 RespondWell, LLC. All rights reserved. RespondWell, LLC is based in Denver, Colorado, with clinicians and pharmacies licensed in all 50 states.Sitemap

    The information on this website is for general informational purposes only and has not been evaluated by the FDA. It is not a substitute for professional medical advice, diagnosis, or treatment. RespondWell connects first responders with independent licensed providers and pharmacies to improve access to culturally competent care. RespondWell does not practice medicine, prescribe medications, or operate pharmacies — all clinical services are delivered by independent clinicians. Prescriptions require a licensed provider's approval after a medical evaluation; not all patients will qualify. Based on your needs, a provider may prescribe brand-name, generic, or compounded medications. Compounded drugs are not FDA-approved and have not undergone FDA review for safety, effectiveness, or quality. RespondWell does not claim any compounded product is equivalent to, or associated with, any branded or FDA-approved drug. Results vary; no guarantees are made. In a medical emergency, call 911 or go to the nearest ER. Telehealth services and prescriptions may not be available in all states. Safety Information.

    By accessing this website, you agree to our Terms of Use, Privacy Policy, Notice of Privacy Practices, Telehealth Consent, and SMS / Messaging Terms.